Inactivation of the FGF-4 gene in embryonic stem cells alters the growth and/or the survival of their early differentiated progeny

Developmental Biology

Volumn 192, Issue 2, 1997, Pages 614-629

  Wilder, Phillip J ^a   Kelly, David ^a   Brigman, Kristen ^a   Peterson, Cynthia L ^c   Nowling, Tamara ^a   Gao, Qing Sheng ^a   McComb, Rodney D ^b   Capecchi, Mario R ^c   Rizzino, Angie ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^c UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL; ARTICLE; CELL GROWTH; CELL SURVIVAL; EMBRYO DEVELOPMENT; GENE REPRESSION; IMPLANTATION; NONHUMAN; PRIORITY JOURNAL; PROGENY;

ANIMALIA; MAMMALIA; RODENTIA;

EID: 0031573953     PISSN: 00121606     EISSN: None     Source Type: Journal    
DOI: 10.1006/dbio.1997.8777     Document Type: Article

References (53)

1. Adamson E. D., Ayers S. E. The localization and synthesis of some collagen types in developing mouse embryos. Cell. 16:1979;953-965.
2. Amaya E., Stein P. A., Musci T. J., Kirschner M. W. FGF signalling in the early specification of mesoderm inXenopus. Development. 118:1993;477-487.
3. Atencia R., Garcia-Sanz M., Unda F., Arechaga J. Apoptosis during retinoic-induced differentiation of F9 embryonal carcinoma cells. Exp. Cell Res. 214:1994;663-667.
4. Brookes S., Smith R., Thurlow J., Peters G. The nucleotide homologue ofhst/kint-2. Nucleic Acids Res. 17:1989;4037-4045.
5. Chauhan S. S., Gottesman M. M. Construction of a new universal vector for insertional mutagenesis by homologous recombination. Gene. 120:1992;281-285.
6. Chisaka O., Capecchi M. R. Regionally restricted developmental defects resulting from targeted disruption of the mouse homeobox gene hox-1.5. Nature. 350:1991;473-479.
7. Colvin J. S., Bohne B. A., Harding G. W., McEwen D. G., Ornitz D. M. Skeletal overgrowth and deafness in mice lacking fibroblast growth factor receptor 3. Nature Genet. 12:1996;390-397.
8. Condie B. G., Capecchi M. R. Mice homozygous for a targeted disruption of Hoxd-3 (Hox- 4.1) exhibit anterior transformations of the first and second cervical vertebrae, the atlas and the axis. Development. 119:1993;579-595.
9. Deng C., Capecchi M. R. Reexamination of gene targeting frequency as a function of the extent of homology between the targeting vector and the target locus. Mol. Cell. Biol. 12:1992;3365-3371.
10. Deng C.-X., Wynshaw-Boris A., Shen M. M., Daugherty C., Ornitz D. M., Leder P. Murine FGFR-1 is required for early postimplantation growth and axial organization. Genes Dev. 8:1994;3045-3057.
11. Deng C. X., Wynshaw-Boris A., Zhou F., Kuo A., Leder P. Fibroblast growth factor receptor 3 is a negative regulator of bone growth. Cell. 84:1996;911-921.
12. Doetschman T. C., Eistetter H., Katz M., Schmidt W., Kemler R. Thein vitro. J. Embryol. Exp. Morphol. 87:1985;27-45.
13. Duprez D. M., Kostakopoulou K., Francis-West P. H., Tickle C., Brickell P. M. Activation of Fgf-4 and HoxD gene expression by BMP-2 expressing cells in the developing chick limb. Development. 122:1996;1821-1828.
14. Feldman B., Poueymirou W., Papaiannou V. E., DeChiara T. M., Goldfarb M. Requirement of FGF-4 for postimplantation mouse development. Science. 267:1995;246-249.
15. Gunning P., Ponte P., Okayama H., Engel J., Blau H., Kedes L. Isolation and characterization of full-length cDNA clones for human alpha-, beta-, and gamma-actin mRNAs: Skeletal but not cytoplasmic actins have an amino-terminal cysteine that is subsequently removed. Mol. Cell. Biol. 3:1983;787-795.
16. Guo L. F., Degenstein L., Fuchs E. Keratinocyte growth factor is required for hair development but not for wound healing. Genes Dev. 10:1996;165-175.
17. Haramis A. G., Brown J. M., Zeller R. The limb deformity mutation disrupts the SHH/FGF-4 feedback loop and regulation of 5′ HoxD genes during limb pattern formation. Development. 121:1995;4237-4245.
18. Heath J. K., Rees A. R. Growth factors in mammalian embryogenesis. Ciba Found. Symp. 116:1985;3-22.
19. Hébert J. M., Rosenquist T., Gotz J., Martin G. R. FGF5 as a regulator of the hair growth cycle: Evidence from targeted and spontaneous mutations. Cell. 78:1994;1017-1025.
20. Hogan B. L. M. High molecular weight extracellular proteins synthesized by endoderm cells derived from mouse teratocarcinoma cells and normal extraembryonic membranes. Dev. Biol. 76:1980;275-285.
21. Laufer E., Nelson C. E., Johnson R. L., Morgan B. A., Tabin C. Sonic hedgehog and Fgf-4 act through a signaling cascade and feedback loop to integrate growth and patterning of the developing limb bud. Cell. 79:1994;993-1003.
22. Ma Y.-G., Rosfjord E., Huebert C., Wilder P., Tiesman J., Kelly D., Rizzino A. Transcriptional regulation of the murine k-FGF gene in embryonic cell lines. Dev. Biol. 154:1992;45-54.
23. Mansour S. L., Goddard J. M., Capecchi M. R. Mice homozygous for a targeted disruption of the proto-oncogene int-2 have developmental defects in the tail and inner ear. Development. 117:1993;13-28.
24. Mansour S. L., Thomas K. R., Capecchi M. R. Disruption of the proto-oncogene int-2 in mouse embryo- derived stem cells: a general strategy for targeting mutations to non-selectable genes. Nature. 336:1988;348-352.
25. Mansour S. L., Thomas K. R., Deng C., Capecchi M. R. Introduction of a lacZ reporter gene into the mouse int-2 locus by homologous recombination. Proc. Natl. Acad. Sci. USA. 87:1990;7688-7692.
26. Marotti K. R., Berlin D., Strickland S. The production of distinct forms of plasminogen activator by mouse embryonic cells. Dev. Biol. 90:1982;154-159.
27. Miller K., Rizzino A. Developmental regulation and signal transduction pathways of fibroblast growth factors and their receptors. Growth Factors and Signal Transduction in Development. 1994;Wiley-Liss, New York. p. 19-49.
28. Miller K., Rizzino A. Characterization of Fibroblast Growth Factor Activity Secreted by Embryonal Carcinoma Cells. In Vitro Cell. Dev. Biol. 32:1996a;531-533.
29. Miller K., Rizzino A. Constitutive expression of fibroblast growth factor-4 does not alter the growth or the differentiation of embryonal carcinoma cells. Cell Growth Differ. 7:1996b;203-211.
30. Miller K., Wilder P. J., Rizzino A. Fibroblast growth factor complexed to the cytotoxin saporin is growth inhibitory but not cytotoxic for embryonal carcinoma cells. Cytotechnology. 13:1993;69-78.
31. Miller S. A., Dykes D. D., Polesky H. F. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 16:1988;1215.
32. Muenke M., Schell U., Hehr A., Robin N. H., Losken H. W., Schinzel A., Pulleyn L. J., Rutland P., Reardon W., Malcolm S., Winter R. M. A common mutation in the fibroblast growth factor receptor 1 gene in Pfeiffer syndrome. Nature Genetics. 8:1994;269-274.
33. Mummery C. L., van Rooyen M., Bracke M., Van Den Eijnden-van Raaij J., van Zoelen E. J., Alitalo K. Fibroblast growth factor-mediated growth regulation and receptor expression in embryonal carcinoma and embryonic stem cells and human germ cell tumours. Biochem. Biophys. Res. Commun. 191:1993;188-195.
34. Nagy A., Rossant J., Nagy R., Abramow-Newerly W., Roder J. C. Derivation of completely cell culture-derived mice from early-passage embryonic stem cells. Proc. Natl. Acad. Sci. USA. 90:1993;8424-8428.
35. Niswander L., Martin G. FGF-4 expression during gastrulation, myogenesis, limb and tooth development in the mouse. Development. 114:1992;755-768.
36. Rappolee D. A., Basilico C., Patel Y., Werb Z. Expression and function of FGF-4 in peri-implantation development in mouse embryos. Development. 120:1994;2259-2269.
37. Rappolee D. A., Sturm K., Schultz G., Pedersen R., Werb Z. Expression of growth factor ligands and receptors in preimplantation mouse embryos. Heyner S., Wiley L. Early Embryo Development and Paracrine Relationships. 1990;11-25 Wiley-Liss, New York.
38. Reardon W., Winter R. M., Rutland P., Pulleyn L. J., Jones B. M., Malcolm S. Mutations in the fibroblast growth factor receptor 2 gene cause Crouzon syndrome. Nature Genet. 8:1994;98-103.
39. Rizzino A. Understanding the roles of growth factors in carcinogenesis: Modulation of autocrine growth control by differentiation. Int. J. Dev. Biol. 37:1993;61-65.
40. Rizzino A., Kuszynski C., Ruff E., Tiesman J. Production and utilization of growth factors related to fibroblast growth factor by embryonal carcinoma cells and their differentiated cells. Dev. Biol. 129:1988;61-71.
41. Rizzino A., Ruff E. Fibroblast growth factor induces the soft agar growth of two non-transformed cell lines. In Vitro Cell. Dev. Biol. 22:1986;749-755.
42. Rousseau F., Bonaventure J., Legeai-Mallet L., Pelet A., Rozet J.-M., Maroteaux P., Le Merrer M., Munnich A. Mutations in the gene encoding fibroblast growth factor receptor-3 in achondroplasia. Nature. 371:1994;252-254.
43. Shiang R., Thompson L. M., Zhu Y.-Z., Church D. M., Fielder T. J., Bocian M., Winokur S. T., Wasmuth J. J. Mutations in the transmembrane domain of FGFR3 cause the most common genetic form of dwarfism, achondroplasia. Cell. 78:1994;335-342.
44. Singer P. A., Trevor K., Oshima R. G. Molecular cloning and characterization of the Endo B cytokeratin expressed in preimplantation mouse embryos. J. Biol. Chem. 261:1986;538-547.
45. Smallwood P. M., Munoz-Sanjuan I., Tong P., Macke J. P., Hendry S. H. C., Gilbert D. J., Copeland N. G., Jenkins N. A., Nathans J. Fibroblast growth factor (FGF) homologous factors: New members of the FGF family implicated in nervous system development. Proc. Natl. Acad. Sci. USA. 93:1996;9850-9857.
46. Thomas K. R., Capecchi M. R. Site-directed mutagenesis by gene targeting in mouse embryo-derived stem cells. Cell. 51:1987;503-512.
47. Tiesman J., Meyer A., Hines R. N., Rizzino A. Production of growth factors related to fibroblast growth factor and platelet-derived growth factor by human embryonal carcinoma cells. In Vitro Cell. Dev. Biol. 24:1988;1209-1216.
48. Tiesman J., Rizzino A. Expression and developmental regulation of the k-FGF oncogene in human and murine embryonal carcinoma cells. In Vitro Cell. Dev. Biol. 25:1989;1193-1198.
49. Ucker D. S., Obermiller P. S., Eckhart W., Apgar J. R., Berger N. A., Meyers J. Genome digestion is a dispensable consequence of physiological cell death mediated by cytotoxic T lymphocytes. Mol. Cell. Biol. 12:1992;3060-3069.
50. Velcich A., Delli-Bovi P., Mansukhani A., Ziff E. B., Basilico C. Expression of the K-fgf protooncogene is repressed during differentiation of F9 cells. Oncogene Res. 5:1989;31-37.
51. Yamaguchi T. P., Harpal K., Henkemeyer M., Rossant J. fgfr-1. Genes Dev. 8:1994;3032-3044.
52. Yamasaki M., Miyake A., Tagashira S., Itoh N. Structure and expression of the rat mRNA encoding a novel member of the fibroblast growth factor family. J. Biol. Chem. 271:1996;15918-15921.
53. Yoshida T., Muramatsu H., Muramatsu T., Sakamoto H., Katoh O., Sugimura T., Terada M. Differential expression of two homologous and clustered oncogenes, Hst1 and Int-2, during differentiation of F9 cells. Biochem. Biophys. Res. Commun. 157:1988;618-625.